CD38 항체의 제제 및 그의 용도
본 발명은 CD38에 결합하는 항체를 포함하는 제약 제제 및 암 및 다른 적응증의 치료에서의 상기 제제의 용도를 제공한다. The present invention provides pharmaceutical formulations comprising antibodies binding to CD38 and to the use of said formulations in the treatment of cancer and other indications....
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | Korean |
| Published |
27.09.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 본 발명은 CD38에 결합하는 항체를 포함하는 제약 제제 및 암 및 다른 적응증의 치료에서의 상기 제제의 용도를 제공한다.
The present invention provides pharmaceutical formulations comprising antibodies binding to CD38 and to the use of said formulations in the treatment of cancer and other indications. |
|---|---|
| AbstractList | 본 발명은 CD38에 결합하는 항체를 포함하는 제약 제제 및 암 및 다른 적응증의 치료에서의 상기 제제의 용도를 제공한다.
The present invention provides pharmaceutical formulations comprising antibodies binding to CD38 and to the use of said formulations in the treatment of cancer and other indications. |
| Author | CLAUSEN JACOB D HIBBERT RICHARD DALGAARD MICHAEL B |
| Author_xml | – fullname: DALGAARD MICHAEL B – fullname: CLAUSEN JACOB D – fullname: HIBBERT RICHARD |
| BookMark | eNrjYmDJy89L5WRQd3YxtlB4O3Xtm01b3sydofBmwRwgUni9oV_h1fYdYJFZK1_3t_AwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUknjvICMDIyMDQ2MDcyMTR2PiVAEAxPIy6w |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | KR20220130724A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_KR20220130724A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:22:45 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_KR20220130724A3 |
| Notes | Application Number: KR20227027611 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220927&DB=EPODOC&CC=KR&NR=20220130724A |
| ParticipantIDs | epo_espacenet_KR20220130724A |
| PublicationCentury | 2000 |
| PublicationDate | 20220927 |
| PublicationDateYYYYMMDD | 2022-09-27 |
| PublicationDate_xml | – month: 09 year: 2022 text: 20220927 day: 27 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | GENMAB A |
| RelatedCompanies_xml | – name: GENMAB A |
| Score | 3.3865042 |
| Snippet | 본 발명은 CD38에 결합하는 항체를 포함하는 제약 제제 및 암 및 다른 적응증의 치료에서의 상기 제제의 용도를 제공한다.
The present invention provides pharmaceutical formulations comprising antibodies binding... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | CD38 항체의 제제 및 그의 용도 |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220927&DB=EPODOC&locale=&CC=KR&NR=20220130724A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTFLAnbRTC10zSwSE3VNUlJTdZOMzY11zVJMkkCHvSSnGIL2Dvv6mXmEmnhFmEYwMeTA9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjv2MjIwNLIXM3FydY1wN_F31nN2dnWO0jNLwgiByyvzY1MHJkZWEENadBJ-65hTqB9KQXIlYqbIANbANC8vBIhBqbsfGEGTmfY3WvCDBy-0ClvIBOa-4pFGNSdXYwtFN5OXftm05Y3c2covFkwB4gUXm_oV3i1fQdYZNbK1_0togzKbq4hzh66QBvj4R6M9w5Cdp6xGAMLsOufKsGgYGxsnJqUnGqcmJJqapIEbAmZmxolARsNZoapFsmpSZaSDDL4TJLCLy3NwAXiglY_GJnLMLCUFJWmygKr2JIkOXDIAAAeI4dT |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTFLAnbRTC10zSwSE3VNUlJTdZOMzY11zVJMkkCHvSSnGIL2Dvv6mXmEmnhFmEYwMeTA9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjv2MjIwNLIXM3FydY1wN_F31nN2dnWO0jNLwgiByyvzY1MHJkZWM1B5_OCGk9hTqB9KQXIlYqbIANbANC8vBIhBqbsfGEGTmfY3WvCDBy-0ClvIBOa-4pFGNSdXYwtFN5OXftm05Y3c2covFkwB4gUXm_oV3i1fQdYZNbK1_0togzKbq4hzh66QBvj4R6M9w5Cdp6xGAMLsOufKsGgYGxsnJqUnGqcmJJqapIEbAmZmxolARsNZoapFsmpSZaSDDL4TJLCLy3PwOkR4usT7-Pp5y3NwAWSAq2EMDKXYWApKSpNlQVWtyVJcuBQAgCaZIpA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CD38+%ED%95%AD%EC%B2%B4%EC%9D%98+%EC%A0%9C%EC%A0%9C+%EB%B0%8F+%EA%B7%B8%EC%9D%98+%EC%9A%A9%EB%8F%84&rft.inventor=DALGAARD+MICHAEL+B&rft.inventor=CLAUSEN+JACOB+D&rft.inventor=HIBBERT+RICHARD&rft.date=2022-09-27&rft.externalDBID=A&rft.externalDocID=KR20220130724A |